Antimicrobial resistance in carceral settings
Lancet
.
2024 Sep 14;404(10457):1015-1016.
doi: 10.1016/S0140-6736(24)01693-3.
Authors
Samuel Wilk
1
,
Jacinda C Abdul-Mutakabbir
2
,
Shira Doron
3
,
Christina Yen
4
,
Justin Berk
5
,
Alysse Wurcel
6
Affiliations
1
Tufts University School of Medicine, Boston, MA 02111, USA. Electronic address:
[email protected]
.
2
Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, USA.
3
Tufts Medical Center, Boston, MA, USA.
4
MaineHealth, Portland, ME, USA.
5
Warren Alpert Medical School, Brown University, Providence, RI, USA.
6
Tufts University School of Medicine, Boston, MA 02111, USA; Tufts Medical Center, Boston, MA, USA.
PMID:
39277283
DOI:
10.1016/S0140-6736(24)01693-3
No abstract available
Publication types
Letter
MeSH terms
Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Humans
Incarceration*
Substances
Anti-Bacterial Agents